Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -353,046 | -76,643 | -361,918 | -221,023 | -144,630 |
| Depreciation Amortization | 5,313 | 1,403 | 4,573 | 3,976 | 2,297 |
| Accounts receivable | -7,937 | -1,466 | -19,576 | -19,133 | -13,517 |
| Other Working Capital | -101,001 | -93,919 | -107,892 | -104,104 | -46,389 |
| Other Operating Activity | 231,434 | 24,392 | 96,153 | 74,044 | 49,317 |
| Operating Cash Flow | $-225,237 | $-146,233 | $-388,660 | $-266,240 | $-152,922 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 494,559 | 152,349 | -305,790 | -88,812 | -46,580 |
| PPE Investments | -32,945 | -16,263 | -61,157 | -40,954 | -20,863 |
| Net Acquisitions | -172,556 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -353 | -353 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2,633 | -1,556 |
| Other Investing Activity | -1,454 | -855 | -3,541 | -2,633 | -1,556 |
| Investing Cash Flow | $287,604 | $135,231 | $-370,488 | $-132,752 | $-69,352 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 235,872 | 217,722 | 173,354 |
| Debt Repayment | N/A | N/A | -267,219 | -249,896 | -174,918 |
| Common Stock Issued | 384,744 | 377,563 | 563,631 | 43,031 | 34,386 |
| Other Financing Activity | -889 | 0 | -2,134 | -1,990 | 0 |
| Financing Cash Flow | $383,855 | $377,563 | $530,150 | $8,867 | $32,822 |
| Beginning Cash Position | 370,829 | 370,829 | 599,827 | 599,827 | 599,827 |
| End Cash Position | 817,051 | 737,390 | 370,829 | 209,702 | 410,375 |
| Net Cash Flow | $446,222 | $366,561 | $-228,998 | $-390,125 | $-189,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -225,237 | -146,233 | -388,660 | -266,240 | -152,922 |
| Capital Expenditure | -32,945 | -16,263 | -61,157 | -40,954 | -20,863 |
| Free Cash Flow | -258,182 | -162,496 | -449,817 | -307,194 | -173,785 |